Borderline tumors of the ovary (also called tumors of low-malignant potential) are a heterogeneous group of lesions defined histologically by atypical epithelial proliferation without stromal invasion. The epidemiology, diagnosis, and treatment of borderline ovarian tumors are reviewed here. Borderline ovarian epithelial neoplasms are noninvasive neoplasms that occasionally have intraperitoneal spread. This group of neoplasms exhibit behavior that is intermediate between benign cystadenomas and invasive carcinomas. These have been referred to by different terms, including: borderline, atypical proliferative, and tumors of low-malignant potential. Borderline neoplasm is currently the most widely used designation by pathologists, gynecologists, and oncologists, and has been adopted into the World Health Organization classification. Borderline tumors account for 14 to 15 percent of all primary ovarian neoplasms
For More Views: http://www.sciaeon.org/womens-health-and-complications/home
Article page: http://www.sciaeon.org/womens-health-and-complications/articles-in-press
Contribute your manuscript: http://www.sciaeon.org/submit-paper
For more queries: whc@sciaeonopenaccess.com
Women's Health and Complications 